Novel miRNA biomarker and treatment of memory impairment
Age associated dementia consist a serious health and social problem for our society, with their prevalence increasing as lifespan expands. Efficient therapeutic strategies to treat memory decline are still missing. Scientists of the University of Göttingen have now developed a new biomarker and medical approach for treatment of dementia and of other memory impairment conditions. This includes discovery of a new microRNA (miRNA) biomarker associated with learning and memory and its therapeutic manipulation, in particular to rescue learning impairment in dementia.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light. The method, invented by scientists at the University of…
Insect research is revolutionized by technology
New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…
X-ray satellite XMM-newton sees ‘space clover’ in a new light
Astronomers have discovered enormous circular radio features of unknown origin around some galaxies. Now, new observations of one dubbed the Cloverleaf suggest it was created by clashing groups of galaxies….